Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

HIV Infections

Interventions

DRUG

Placebo

Placebo for 14 days

DRUG

Aprepitant

Aprepitant at a dose of 125 mg daily for 14 days

DRUG

Aprepitant

Aprepitant at a dose of 250 mg daily for 14 days

Trial Locations (1)

Clinical Trials Unit. University of Pennsylvania, Philadelphia

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pennsylvania

OTHER

NCT00428519 - Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals | Biotech Hunter | Biotech Hunter